Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Vestibulocortical Stimulation for Fibromyalgia: A Quick Bedside Test

Official title: Vestibular Innovation in Pain: A Randomized Controlled Trial

Run by Icahn School of Medicine at Mount Sinai · NCT07423377 · Data updated 2026-11-12

This trial tests whether a single bedside vestibulocortical stimulation session using temperate water can reduce pain and improve quality of life in adults with fibromyalgia compared with a sham procedure.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment56 (estimated)
SponsorIcahn School of Medicine at Mount Sinai
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedMarch 19, 2026
Main results expectedJuly 31, 2027
Study endsJuly 31, 2027
Registry record updatedJune 8, 2026
Trial IDNCT07423377 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) diagnosed with fibromyalgia who are willing to undergo VCS, can complete online outcomes, and have access to a device for reporting results.

Probably not a fit

Participants with certain ear conditions, pregnancy, or specific neurological/psychiatric histories may not benefit or could be at risk.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Fibromyalgia is treated with limited success and notable side effects, so this study explores a simple, low-cost bedside technique called vestibulocortical stimulation (VCS). Participants receive one VCS session or a sham procedure and report pain and quality of life using validated questionnaires. The trial uses a randomized, sham-controlled design to determine if VCS produces meaningful short-term benefits. Eligible adults must have fibromyalgia, consent, access to a digital device, and English fluency. Safety considerations focus on ear health, with exclusions for recent ear issues, pregnancy, and certain psychiatric or neurological histories.

Why it matters

Potential benefit: If successful, patients may experience faster relief from pain and improved daily functioning with a safe, inexpensive intervention.

How similar studies have gone: Prior data from related approaches suggest potential pain relief, but this direct VCS method is novel in this context and requires confirmation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Provision of signed and dated informed consent form
* Age equal to or \>18 years old
* Stated interest in and willingness to receive VCS and to complete the online patient reported outcomes before and after the procedure.
* Owns or has access to a smart phone or computer to complete outcome measures
* Fluency in English
* Diagnosis of Fibromyalgia (FM)

  * Diagnosis by American College of Rheumatology 2016 questionnaire
  * Pain score 4/10 or more and less than 10/10 on the numeric rating scale at the time of inclusion.

Exclusion Criteria:

* History of tympanic membrane injury, rupture, or surgery a. Including tympanostomy, or "ear tubes," and/or cochlear implant.
* Right ear infection within the last 3 months, or current right ear pain.
* Current pregnancy
* Bipolar Disorder
* History of seizures (including non-epileptiform seizures)
* History of syncope within the last 3 months. a. Not including presyncope or in setting of known medical illness (i.e., heatstroke)
* Inability to lay supine for 15 minutes
* Receiving disability benefits for fibromyalgia or involved in litigation related to fibromyalgia.
* Clinically significant medical, psychological, or behavioral conditions that, in the opinion of the investigator, would compromise participation in the study.
* History of or current Meniere's Disease
* History of myocardial infarction (MI), stroke or TIA, or coronary artery bypass graft (CABG) in the last 3 months
* History of hospitalization for severe hypertension
* History of vestibular schwannoma or meningioma resection.
* Patients taking opioid therapy (not including tramadol).

Where it's running

  • Mount Sinai West
    New York, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Michael Kaplan, MD — Mount Sinai Hospital, Icahn School of Medicine
  • Study coordinator: Talia Torkian
  • Email: viptrial@mountsinai.org
  • Phone: 212-241-1671

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.